Patent ID: 7623971

Claim:
A process for controlling disease in aquatic animals at an end user location, comprising: (a) testing a range of candidates including at least one of: (i) Bacillus species, (ii) Bacillus strains, (iii) species of beneficial bacteria (iv) strains of beneficial bacteria and (v) strains of beneficial bacterial viruses, against samples including at least one of pathogenic Vibrio ,Gram negative pathogenic bacteria and Gram positive pathogenic bacteria taken from an end user location; performing the step of selecting one or more of the candidates that inhibit and attack at least one of the samples by at least one of in situ antibiotic production, competitive exclusion, and production of enzymes that degrade quorum sensing molecules, (b) testing a range of quorum sensing inhibitor compounds against the samples; and (c) performing the steps (a) and (b) for the end user location, including one of a country, major region and individual end user location, to determine microbial strain composition based on the selected candidate and/or quorum sensing inhibitor compounds and the tested range of quorum sensing inhibitor compounds to formulate a product and target microbial technology for use in bio-control of disease specific to the end user location.